Mer-f3, 12-hydroxy-ovalicin, produced by Metarrhizium sp. f3.
Kuboki
H
H
Tsuchida
T
T
Wakazono
K
K
Isshiki
K
K
Kumagai
H
H
Yoshioka
T
T
D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D016923:Cell Death / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003512:Cyclohexanones / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D009682:Magnetic Resonance Spectroscopy; D003904:Mitosporic Fungi / Q000378:metabolism*; D015394:Molecular Structure; D013141:Spiro Compounds / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003512:Cyclohexanones; D007166:Immunosuppressive Agents; C121130:Mer f3; D013141:Spiro Compounds